As an E3 ubiquitin ligase, PELI1 contributes to lymphoid and several solid (e.g., lung cancer, breast cancer, and melanoma) tumorigenesis [5–10], which has been emphasized as valuable prognostic biomarker and attractive therapeutic targets of cancer. Here, PELI1 is linked to cancer.